Rheumatology Doctors in Billings, MT Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Phillip Embury Griffin, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2938 Rockrim Ln, Billings, MT 59102 Phone: 406-259-7582

John K Jenkins, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 708 Broadwater Ave, Billings, MT 59101 Phone: 406-839-2900    Fax: 406-839-2910

Wendy Lee Donaugh, FNP Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2409 Arnold Ln Ste 9, Billings, MT 59102 Phone: 406-345-5314    Fax: 747-205-0742

Dr. Lawrence P Zyskowski, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500

Mr. Enrico F Arguelles, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 708 Broadwater Avenue, Billings, MT 59101 Phone: 406-839-2900    Fax: 406-839-2910

News Archive

OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis

The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patients with primary biliary cholangitis who have had an incomplete response to ursodeoxycholic acid.

New research may help treat HIV patients without elevating risk for liver disease

As a raft of new treatments for HIV infection have come on the market in the past 20 years, AIDS patients got access to drugs that allowed them to live longer.

Geron second-quarter net loss decreases to $17.0 million

Geron Corporation today reported financial results for the three and six months ended June 30, 2010.

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment

BioCryst Pharmaceuticals, Inc. today announced that the National Institute of Allergy and Infectious Diseases has exercised an option to conduct the investigational new drug enabling program and to submit an IND.

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).

Read more Medical News

› Verified 9 days ago